ScholarIQanswers from OpenAlex

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule

PaperCitations, authors & open-access status

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule have?

ScholarIQcitation count

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule has 284 citations in the OpenAlex counts ScholarIQ stores.

When was A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule published?

ScholarIQyear

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule has 2007 year in the ScholarIQ index.

What is the open-access status of A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule?

ScholarIQoa status

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule has bronze oa status in the ScholarIQ index.

What is the DOI of A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule?

ScholarIQdoi

The DOI for A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule is on the source record.

What is the PMID of A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule?

ScholarIQpmid

The PMID for A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule is on the source record.

What is the OpenAlex record for A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule?

ScholarIQopenalex

The OpenAlex for A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial